The anorexia associated with acute and chronic inflammatory or infectious conditions is poorly understood. Our objectives were to explore the anorexigenic effects of interleukin-1 (IL-1) in the rat. Recombinant human (rh) IL-1,6, murine (rm) IL-la and to a lesser extent rhIL-la significantly reduced food intake at 24.0 gg/kg i.p. but not at lower doses, in young (200-250 g) meal-fed rats on chow diets. The anorexic effect appears to be mediated by prostaglandins since pretreatment with ibuprofen completely blocked it, and a fish oil based diet abolished it, in comparison to corn oil or chow diets. Fish oil feeding also decreased basal and IL-1 stimulated prostaglandin E2 production by tissues in vitro (liver, brain, peritoneal macrophages) and in the whole body. Constant intravenous infusions of lower doses of IL-1 also diminished food intake, though intravenous boluses did not (reflecting rapid renal clearance). Chronic daily administration of IL-1 caused persistent inhibition of food intake for 7-17 d in chow and corn oil fed rats, but had no effect in fish oil fed rats. There was an attenuation of the effect (tachyphylaxis) after 7 d in corn oil and chow fed rats, but slowed weight gain and lower final weights were observed after 17-32 d of daily IL-1. Old (18-20 mo Fisher 344) rats showed less sensitivity to IL-1 induced anorexia. In conclusion, IL-1 is anorexigenic in the rat, but this is influenced by the structural form of IL-1, the route and chronicity of administration, the source of dietary fat, and the age of the animal. The ability of prior fat intake to influence the anorexic response to IL-1 represents a novel nutrient-nutrient interaction with potential therapeutic implications.
Introduction
Both acute and chronic inflammatory conditions as well as infectious diseases are associated with alterations in nutrition and metabolism (1, 2) . One of the most important of these is decreased food intake (anorexia), which can progress to ca-chexia and death by starvation (3, 4) . With its high prevalence in human immunodeficiency virus-infected patients (5-7), cachexia is becoming an increasingly important problem, yet it remains poorly understood. The availability of recombinant cytokines (8, 9) allows experimental testing of new hypotheses about the mediators and mechanisms of the anorexia of inflammation.
Tumor necrosis factor/cachectin (TNF)' has received attention in this regard (9) (10) (11) (12) . Administration of a solution containing macrophage secretory products including TNF suppresses food intake in mice (10) but these preparations contain other cytokines such as IL-I13 (13) in addition to TNF. Tumor cells secreting TNF can induce cachexia in mice (1 1) but again the presence of other mediators cannot be excluded. When given in sublethal doses to mice (12, 13) , recombinant TNF results in decreased appetite and weight loss. However, the effect appears to be short lived ( 12) in addition to requiring escalating doses (13) .
The effect of IL-l on food intake in rats is largely unknown (14) . McCarthy et al. (15) reported decreased intake of a liquid diet in rats given recombinant murine IL-la, but the effect was relatively minor, lasting only for the first hour of refeeding. More recently (16) , rhIL-lB administered to ad lib. fed mice at 6 ,g/kg per d in two divided doses was reported to decrease food intake by 10-15%, a similar quantitative effect as for rhIL-1 a but significantly less than recombinant murine IL-la given at similar doses (40-50% reduction in intake). The effect of IL-1(3 on food intake is relevant to interpretation of TNF effects, since TNF stimulates the release ofIL-1f (16, 17) .
Our objectives in these studies were, first, to develop a quantitative, reproducible and physiologically relevant animal model for the anorexia of inflammatory illnesses, using IL-l. Dose-response relationships, potential mediation by eicosanoid pathways, involvement of central or peripheral appetite regulatory mechanisms, effects of normal aging, differences between the two structural forms of IL-I and persistence of any effects during chronic IL-1 administration were then examined.
Methods
Male Sprague-Dawley rats (Charles River Breeding Laboratories, Wilmington, MA) were trained to a single daily meal (meal-fed) after reaching 150 g body wt. Meal-feeding has advantages over ad lib. feeding for studies of drug or hormone effects on appetite (18, 19) , in that the effects ofanorexigens with a short biological duration ofaction are not lost over a 24-h period, since all intake occurs over 3 h. Mealfed animals grow well and eat amounts comparable to ad lib.-fed rats (20) , and the metabolic and enzymatic consequences of meal-feeding have been well characterized (21, 22 RhIL-I( was produced, purified and characterized as described (8) and consisted of the carboxy-terminal 157 amino acids. This and subsequent lots were active in the rabbit pyrogen test at 100 mg/kg and the mouse lymphocyte activating factor (LAF) assay. The endotoxin concentration in the present preparation was < 60 pg/mg. The specific activity as measured by half-maximal units (LAF) on C3H/He5 mouse thymocytes was 5.5 X 107 U/mg. The rhIL-lI3 was diluted in 0.1% serum which had been dialyzed overnight at 4VC then heated to 560C for 20 min. The diluted rhIL-1If was administered either intravenously or intraperitoneally. RhIL-la and recombinant murine (rm) IL-la were generously provided by Dr. Peter Lomedico (Hoffmann-La Roche, Nutley, NJ). The activity of rmIL-la is 1.3 X 108 U/mg (D 1O.G4. 1 cells, where I LAF unit = 20-50 DI 0 units) and the endotoxin concentration is 0.55 ng/mg protein (LAL). The activity of rhIL-la is 2.5 X I09 U/mg (D0 assay) and the endotoxin concentration is 65 pg/mg protein (LAL). Meal-fed rats (Chow, C.O., or F.O.) given 0.1% serum i.p. or heat inactivated rhIL-IB i.p. 1 h premeal had no change in food intake from baseline.
The technique for placement and maintenance of indwelling intrajugular silastic catheters has been described elsewhere (25) . Catheterization may depress food intake for 24-48 h, therefore no studies were performed for at least 72-96 h after catheter placement, until food intake had stabilized at precatheterization values. A parenteral preparation of ibuprofen (50 mg/ml) was the gift of Upjohn Co. (Kalamazoo, MI) and was administered intravenously or intraperitoneally in sterile 0.45% saline.
48-h urine was collected on dry ice from rats before and after intraperitoneal injection of rhIL-l. The urinary metabolite of PGF2a [ 13,14- dihydro-l 5ketoPGF2a (MetF2a)], an indicator of total body PG production, was extracted using a Sep-pak C18 cartridge (Waters Associates, Milford, MA) as described by Powell (26) . MetF2a in the extracts was measured by RIA as described previously (27) , and urinary creatinine was measured by Roche Cobas Fara Centrifugal Analyzer (Nutley, NJ) using Roche Diagnostic Systems Reagent and procedure number 44905, a modification of the method of Larson (28 Different structural forms and species sources of recombinant IL-I were also tested. RhIL-1 a was less anorexigenic than rhIL-1I3 in chow-fed rats (although this did not reach statistical significance), while the effect of rmIL-la was similar to that of rhIL-1I3 (Table I) . Anorexia from intraperitoneal rmIL-la, as from intraperitoneal rhIL-1I, was completely blocked by ibuprofen 10 mg/kg i.v. (not shown). To exclude any possible effects due to the intravenous route of ibuprofen administration or due to catheterization itself, ibuprofen 10 mg/kg or 0.9% saline were administered to noncatheterized rats by the intraperitoneal route 1 h before rmIL-la 6 jm/kg i.p., (Fig. 2) . IP ibuprofen completely abolished rmIL-la anorexia (food intake 99.4% with ibuprofen/IL-l, 56 .3% with saline/IL-l).
Next, the effect of dietary fat source on IL-1 anorexia was examined (Table I ). Exogenous N-3 fatty acids, which are present at high levels in cold water F.O. (24) are known to reduce PGE2 synthesis in rats (32) as well humans (33) . Groups of rats were chronically fed chow or purified diets based on AIN diet recommendations for rats (34) containing 10% by weight of either F.O. or C.O. Animals were begun on purified diets at 75-100 g body wt and continued for up to 6-10 wk. Composition of tissue fat in growing rats has been shown to be altered by dietary fat source (35) . Serum tocopherol levels in these F.O., C.O. and chow fed rats were comparable (not shown).
The effect ofrhIL-1I3 4 jg/kg or rmIL-la 6 ,jg/kg injections on food intake was significantly different between the F.O. and C.O. groups with chow-fed rats in between (Table I) . Administration of 0.9% saline i.p. had no effect on food intake in any group. The effect of dietary fat source was similar for rmIL-1 a as for rhIL-1, (Table I) . To test the hypothesis that this nutrient-nutrient interaction (prior dietary fat source influencing food intake response to IL-1 administration) is mediated by eicosanoid pathways, PGE2 synthesis was determined in vitro and in vivo in basal and IL-I stimulated states. Consistent with the model, in vivo production of PGs of the 2 series, represented by the urinary excretion of the PGE2a metabolite 13,14-dihydro-1 Sketo-PGF2a (MetF2a) was higher in C.O. fed rats after rhIL-1, injection than in F.O. fed rats (Table II) . Moreover, peritoneal leukocytes from C.O. fed rats synthesized more PGE2 than F.O. fed rats in vitro, both in the presence and absence of rhIL-113 (Table III) . Brain stem and liver homogenates from F.O. fed rats also produced significantly less PGE2 than C.O. and chow fed rats (Table III) , although no such difference was observed in mid-brain.
When rhIL-113 was given intravenously as a 800-ng (4 jig/kg) bolus i h before the daily meal, there was no effect on food intake (Table IV) . The same dose administered by constant intravenous infusion at 200 ng/h over 4 h beginning I h before the meal reduced food intake by 34.8±15.9% (P < 0.005), which was not significantly different from equal doses given intraperitoneally. When rhIL-11 was infused overnight at 80 ng/h for the 20 h before and during the daily 
Tissues were isolated as described in the text. PGE2 was measured by RIA (26) in the supernatant of the incubation media. P values are calculated using two-sample Student's t test for peritoneal macrophage data (two groups) and one-way ANOVA for liver and brainstem data (three groups). Statistics were performed on logarithmically transformed data to resolve unequal variances. * P < 0.09 vs. corn oil fed. P < 0.0001 for overall diet effect by ANOVA. Fish oil significantly different from corn oil and chow (P < 0.05) by Tukey's followup. § P < 0.0012 for overall diet effect by ANOVA. Fish oil significantly different from corn oil and chow (P < 0.05) by Tukey's followup.
meal (1,600 ng total, rhIL-lI was administered intravenously to chronically catheterized rats. Bolus refers to a single injection 1 h before the daily meal. Constant infusions were performed as detailed in the text, using a Harvard infusion pump. Baseline, day one and day two food intakes and P-values for comparison were calculated as described in Fig. 1 . * P < 0.025 vs. baseline. * P < 0.005 vs. baseline. I P < 0.025 vs. group III, day 1 intake. intravenous rhIL-13 infusion partially restored food intake toward baseline values (Table IV) , but not completely. RmIL-la administered at 80 ng/h (400 ng/kg per h) for 20 h also decreased food intake (to 66% baseline) and this was blocked by co-administration of ibuprofen 2.5 mg/kg per h (intake 108% baseline).
The question whether normal aging alters the anorexic effect of rhIL-1 was addressed, because many normal homeostatic responses are diminished with aging (36) and because there exists some evidence (Hellerstein, M. K., unpublished observations) that elderly humans are less able to mount other features of the acute-phase response to inflammation (e.g., fever, leukocytosis, etc.). NIA aged, 18-20-mo old chow-fed Fisher 344 rats had diminished sensitivity to IL-113 anorexia (8.3±3.9% inhibition of food intake, P < 0.05 vs. young chowfed rats).
Finally, we examined the effect ofchronic IL-l administration on food intake and body weight in rats fed different fat sources. These experiments consume large amounts of recombinant protein. Accordingly, only a relatively small number of animals could be studied (5 chow rats, 3 F.O., 3 C.O.). To minimize the possible confounding effects of antibodies to a foreign protein developing with chronic administration in this rodent model, rmIL-la was given. Rats were given daily rmIL-I a 6 gg/kg or 0.1% serum i.p. Average food intake over the first 7 (Fig. 3) . IL-la administration was continued in the C.O. and chow-fed groups beyond the initial 7 d. The anorexic effect in both groups was attenuated during days 8-17 of IL-l administration (Fig. 3) (14) in comparison to the more robust effects on total daily intake shown here with rhIL-l( and rmIL-la has several possible explanations. The liquid diet is not a physiologic form of food and may modify any effects of IL-1 on appetite that are mediated by suppression of gastric motility (41) . Due to rapid t is a useful clearance of administered IL-1f (37) The failure of intravenous boluses of rhIL-l(I (800 ng) to cause any decrease in food intake (Table IV) is probably due to rapid renal clearance of IL-1( (37), in view of the ability of intravenous rhIL-1(3 or rmIL-1 a continuously infused at lower doses to suppress food intake. The inability of acetaminophen, which preferentially inhibits brain cyclooxygenase relative to that in peripheral tissues (30, 31) , to block rhIL-lB anorexia Cr -0-C supports a peripheral mechanism. The inability of intravenous ---Control Rats ibuprofen to completely block the anorexic effect of pro-----IL-I Rats longed, low dose rhIL-1( infusion also suggests that other mechanisms besides PGE2 production may be involved in this setting, although other explanations are possible since PG production was not measured. These questions require further study.
The finding that normal aging decreases sensitivity to the 35 anorexic effect of rhIL-1( is of interest. One might have expected a greater effect on food intake in these old, presumably less resilient animals. The fact that the opposite was observed b Average indirectly supports the IL-1(3 effect as being part of a "deadministrasigned" physiologic response, which is attenuated with aging, id P < 0.05
in contrast to a model wherein anorexia is a "nonspecific" effect of illness.
By analogy to TNF, the possibility needs to be considered that IL-1 induced suppression of food intake is a toxic effect rather than a primary anorexigenic effect. Daily administration of recombinant human TNF-a to rodents (12) initially caused acute gastrointestinal inflammation, with edema and hemorrhage, followed by rapid recovery within 24-48 h (tolerance). Food intake and weight loss followed a similar time course, with an acute effect followed by rapid tolerance (12) .
However, IL-1 anorexia is unlikely to be due to acute gastrointestinal toxicity, for several reasons. First, extensive toxicity studies in mice and rats using 100-fold higher IL-l doses than were used here have failed to reveal any organ toxicity (Dinarello, C. A., unpublished observations). In fact it is quite difficult to kill a nonadrenalectomized rodent with massive doses of IL-1, in contrast to TNF. Second, one would expect gastrointestinal toxicity to be worsened by prostaglandin inhibition, rather than ameliorated, since PGE2 is cytoprotective in the gut (49, 50) . Finally, the anorexia and slowing of body weight gain that we observed were not restricted to the first 24-48 h of IL-l administration, but persisted for at least 7 d (Figs. 3 and  4) , and withholding of IL-1 for a day during chronic administration immediately restored food intake to normal (not shown).
The effects of chronic rmIL-1 a administration are notable for several reasons. The issue of tachyphylaxis to cytokine anorexia is central if a physiologic role for cytokines in the anorexia of chronic disease is to be considered tenable. Our observations indicate that tachyphylaxis to IL-1 anorexia (attenuation of anorexigenic effects and return of some weight gain) does occur, but equally importantly show at least a 7-d effect for the anorexia at a constant rmIL-1 a dose (Fig. 3) and a net lower weight in the IL-1 treated rats compared to controls after several weeks (Fig. 4) . Thus, IL-1 by itself has long-term nutritional consequences when administered chronically, in this model. Also, the dietary fat effects observed in acute food intake experiments were reproduced for at least the first 7 d of treatment, supporting the physiologic relevance of the acute data. The mechanism for tachyphylaxis was not established by these studies (e.g., development of antibodies to the recombinant IL-1, a well-documented event even in the same species, receptor down-regulation, metabolic adaptations, etc.). The question whether synergy with other cytokines (51, 52) would overcome this attenuation is currently under investigation.
Placed in the larger picture, these findings add support to the concept that nutrients and inflammation are intimately intertwined, in a complex bidirectional fashion mediated by cytokines (Fig. 5) (59) .
From an experimental point of view, the importance ofspecies source and structural form of IL-1 used, dose, chronicity, and route of administration, feeding regimen, dietary fat source and age of animals in determining the effect of IL-1 on food intake needs to be taken into account and specified in future studies.
